Guidance for industry : content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products.

Bibliographic Details
Corporate Authors:	Center for Drug Evaluation and Research (U.S.), Center for Biologics Evaluation and Research (U.S.)
Format:	Government Document Microform Book
Language:	English
Published:	[Rockville, Md.] : Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [1995]
Subjects:	Drugs > Testing > Government policy > United States. Pharmaceutical policy > United States.
Online Access:	URL accesses index of CDER guidance documents, from which a link may be made to the title desired

Available Online